Diabetes

The Pharmacy Times® Diabetes resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

What can we help you find?
[[thumbnail_alt_text]]
Key best practices for protecting pharmacy personnel during the COVID-19 pandemic.
[[thumbnail_alt_text]]
The waivers were approved within days of the states' submissions.
[[thumbnail_alt_text]]
Curtis E. Haas, PharmD, FCCP, editor-in-chief of Pharmacy Times: Directions in Health-System Pharmacy, and chief pharmacy officer for the University of Rochester’s health care system, discusses preparation for potential patient surge due to COVID-19.
[[thumbnail_alt_text]]
Today’s pharmacy hero is Diane Berkley, CPhT. In addition to working full time at a local hospital during the day, Berkley also works part-time at a community pharmacy.
 
[[thumbnail_alt_text]]
The FDA has issued a statement regarding action to help increase the supply of ventilators, ventilator tubing connectors, and ventilator accessories during the COVID-19 pandemic.
[[thumbnail_alt_text]]
Top news of the week from Pharmacy Times® surrounding the novel coronavirus.
[[thumbnail_alt_text]]
The FDA has issued a complete response letter for the supplemental New Drug Application of the investigational medicine empagliflozin 2.5 mg as an adjunct to insulin for adults with type 1 diabetes.
 
[[thumbnail_alt_text]]
The EUA designation allows the test to be used to detect SARS-CoV-2, the virus that causes COVID-19, for the duration of the continuing pandemic.
[[thumbnail_alt_text]]
Many front-line clinicians have been investigating existing medications and repurposing them for COVID-19 treatment.
[[thumbnail_alt_text]]
Pregabalin capsules is used to treat pain caused by nerve damage due to diabetes or shingles infection. 
[[thumbnail_alt_text]]
Hoth Therapeutics and Voltron Therapeutics will collaborate to develop the self-assembling vaccine technology as a means to aid patients at risk of being infected with COVID-19.
[[thumbnail_alt_text]]
Mandatory, scripted patient education and device demonstrations are vital to avoid harm.